Mestastop Solutions have signed a memorandum of understanding with Syngene to provide its proprietary platform for metastasis discovery on a non-exclusive basis to Syngene clients, as per certain terms and
News
Jun 10, 2022
Dec 20, 2024
Dec 19, 2024
